Lab service utilizes Envision Science’s proprietary biomarkers and technology with a goal of improving diagnosis and grading of prostate cancer SECAUCUS, N.J. and MELBOURNE, Australia, July 13, 2023 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the leading provider [...]
Read MoreAustralian biotechs have unearthed a new pot of gold and it has nothing to do with drugs and experimental therapies. Testing had become the latest boom industry. generating hundred of millions of dollars for local firms, [...]
Read MoreClinical diagnostics company Envision Sciences has appointed Scott Richards as its new chief executive officer. Envision is developing and commercialising a pipeline of novel biomarker-based cancer diagnostic and prognostic tests in tissue and blood. Mr Richards [...]
Read More